Feline Infectious Peritonitis (FIP) has long been a devastating disease for cats, with limited treatment options available. However, recent advancements in antiviral research have brought hope in the form of GS-441524 powder. This article delves into the scientific mechanisms behind this promising compound and its potential to revolutionize FIP treatment.
1.General Specification(in stock)
(1)Injection
20mg, 6ml; 30mg,8ml; 40mg,10ml
(2)Tablet
25/45/60/70mg
(3)API(Pure powder)
(4)Pill press machine
https://www.achievechem.com/pill-press
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-2-1-049
GS-441524 CAS 1191237-69-0
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide GS-441524 powder, please refer to the following website for detailed specifications and product information.
What Is GS-441524 Powder and How Does It Work at the Molecular Level?
GS-441524 powder is a nucleoside analog that has shown remarkable efficacy in treating FIP. At its core, this compound is designed to interfere with viral replication, specifically targeting the feline coronavirus responsible for FIP. The molecular structure of GS-441524 closely resembles natural nucleosides, which are the building blocks of RNA and DNA.
Chemical Structure and Properties
GS-441524 is a small molecule with a molecular formula of C12H13N5O4. Its structure includes a modified ribose sugar and a purine base, which allows it to mimic natural nucleosides. This structural similarity is crucial for its antiviral activity, as it enables the compound to be recognized by viral enzymes.
The powder form of GS-441524 is typically white to off-white in color and is highly soluble in water. This solubility is essential for its bioavailability and ability to be absorbed by cells. The stability of GS-441524 powder under various storage conditions is an important factor considered by researchers and GS-441524 powder suppliers.
Molecular Targets and Interactions
At the atomic level, GS-441524 targets the RNA-dependent RNA polymerase (RdRp) of the cat coronavirus. This chemical is dependable for duplicating the viral genome, making it a basic target for antiviral treatment. By connection with RdRp, GS-441524 disturbs the virus's capacity to replicate, viably ending its spread inside the have organism. The compound's capacity to specifically target viral chemicals whereas minimizing intelligent with have cell forms is a key figure in its restorative potential. This selectivity makes a difference diminish the hazard of unfavorable impacts on the cat's ordinary cellular functions.
Nucleoside Analog Mechanism and Viral RNA Chain Termination
The antiviral activity of GS-441524 is established in its work as a nucleoside analog. This course of compounds works by imitating the characteristic building pieces of hereditary fabric, interferometer with viral replication through a prepare known as chain termination.
Incorporation into Viral RNA
When the cat coronavirus starts to reproduce inside have cells, it employments the cell's apparatus to create unused duplicates of its RNA genome. Amid this prepare, GS-441524, in its dynamic frame, competes with normal nucleosides for joining into the developing RNA chain. The viral RNA polymerase, incapable to recognize between GS-441524 and characteristic nucleosides, joins the analog into the creating viral RNA strand. This consolidation is the to begin with step in the chain end handle. Once GS-441524 is coordinates into the viral RNA, it sets the arrange for disturbing assist prolongation of the hereditary material.
Chain Termination Mechanism
The key to GS-441524's antiviral action lies in its capacity to end the viral RNA chain. Once joined, the compound needs the essential chemical bunch (regularly a 3'-hydroxyl gather) required for the expansion of ensuing nucleotides. This nonattendance viably ends the stretching of the viral RNA strand. As a result, the infection produces fragmented and non-functional RNA parts, which are unable of supporting viral replication or the generation of basic viral proteins. This component successfully stops the infection in its tracks, avoiding it from creating modern irresistible particles.
Impact on Viral Fitness
The chain end initiated by GS-441524 has a significant affect on viral wellness. Not as it were does it avoid the generation of total viral genomes, but it moreover leads to the aggregation of flawed viral particles. These particles may still be delivered by contaminated cells but need the hereditary fabric vital to build up unused infections. This lessening in viral wellness is vital in permitting the cat's safe framework to pick up an upper hand in controlling the disease. As the generation of utilitarian viral particles diminishes, the resistant framework can more successfully clear contaminated cells and leftover viral components.
Conversion Process into Active Triphosphate Inside Cells
The travel of GS-441524 from an idle powder to an dynamic antiviral specialist includes a basic change handle inside have cells. This intracellular enactment is fundamental for the compound to apply its restorative impacts against the cat coronavirus.
Cellular Uptake and Initial Phosphorylation
Upon entering the cell, GS-441524 experiences a arrangement of phosphorylation steps. The to begin with phosphorylation is frequently the rate-limiting step and is catalyzed by cellular kinases. This introductory phosphorylation is vital as it traps the compound inside the cell and sets the arrange for encourage activation.
Subsequent Phosphorylation Steps
Following the beginning phosphorylation, GS-441524 experiences two more phosphorylation occasions, eventually coming about in the arrangement of GS-441524 triphosphate. This triphosphate frame is the dynamic metabolite that interatomic with the viral RNA polymerase. The effectiveness of this change handle can shift between cell sorts and may impact the generally adequacy of the treatment.
How GS-441524 Powder Interferes with Viral Replication Enzymes?
The interaction between the enacted frame of GS-441524 and viral replication chemicals is at the heart of its antiviral action. This obstructions disturbs the virus's capacity to replicate, viably ending the movement of FIP.
Competitive Inhibition of RNA Polymerase
GS-441524 powder triphosphate acts as a competitive inhibitor of the viral RNA-dependent RNA polymerase (RdRp). It competes with common nucleoside triphosphates for consolidation into the developing RNA chain. The auxiliary likeness of GS-441524 to normal nucleosides permits it to be recognized by the RdRp, but its joining leads to chain termination.
Impact on Viral Enzyme Kinetics
The nearness of GS-441524 triphosphate modifies the energy of viral RNA blend. As the compound is joined into the viral RNA, it moderates down the generally rate of replication and increments the blunder rate in viral genome union. This double impact of abating and presenting mistakes advance compromises the virus's capacity to deliver reasonable progeny.
Cellular Targeting and Inhibition of Feline Coronavirus Replication
The effectiveness of GS-441524 in treating FIP is partly due to its ability to target specific cell types and inhibit viral replication within these cells.
Tropism for Infected Cells
GS-441524 illustrates a special impact on cells contaminated with the cat coronavirus. This tropism is likely due to the higher metabolic movement in tainted cells, which leads to expanded take-up and enactment of the compound. This particular focusing on makes a difference minimize potential side impacts on solid cells.
Reduction of Viral Load
By restraining viral replication, GS-441524 altogether decreases the viral stack in tainted cats. This decrease is significant for overseeing FIP, as it permits the cat's resistant framework to recapture control and clear the remaining viral particles. The diminish in viral stack moreover makes a difference reduce the fiery reactions related with FIP, contributing to clinical improvement.
Conclusion
The science behind GS-441524 powder uncovers a advanced approach to combating FIP. Its instrument of activity, from cellular take-up to viral RNA chain end, illustrates the compound's potential as a capable instrument in cat medication. As investigate proceeds, the experiences picked up from examining GS-441524 may clear the way for indeed more compelling medications for FIP and possibly other viral diseases. While GS-441524 offers trust for cats influenced by FIP, it's vital to note that its utilize ought to be beneath veterinary supervision. The progressing inquire about and clinical trials proceed to refine our understanding of its adequacy and ideal utilize in cat patients.
FAQ
Treatment duration with GS-441524 for FIP typically ranges from 12 to 84 days, depending on the severity of the case and the cat's response to treatment. However, some veterinarians may recommend longer courses to ensure complete viral clearance.
While GS-441524 is generally well-tolerated, some cats may experience mild side effects such as gastrointestinal upset or injection site reactions. Serious side effects are rare, but monitoring by a veterinarian during treatment is essential.
Currently, GS-441524 is not recommended for preventative use. It is specifically designed for treating active FIP infections. Research is ongoing to determine its potential in preventing FIP in high-risk cats, but at present, it is used solely as a treatment option.
Unlock the Power of GS-441524 Powder with BLOOM TECH
As a leading GS-441524 powder supplier, BLOOM TECH is committed to advancing feline health through cutting-edge solutions. Our high-quality GS-441524 powder is produced under stringent GMP conditions, ensuring purity and efficacy. With our 12 years of experience in organic synthesis and our state-of-the-art facilities, we offer unparalleled expertise in the production of pharmaceutical intermediates.
Don't let FIP devastate feline lives. Partner with BLOOM TECH for reliable, high-quality GS-441524 powder and join the fight against FIP. Our dedicated team is ready to support your research and treatment needs. Contact us today at Sales@bloomtechz.com to learn more about how our GS-441524 powder can make a difference in your veterinary practice or research.
References
1. Murphy, B. G., et al. (2020). "The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies." Veterinary Microbiology, 219: 108453.
2. Pedersen, N. C., et al. (2019). "Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis." Journal of Feline Medicine and Surgery, 21(4): 271-281.
3. Kim, Y., et al. (2020). "Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses." Journal of Virology, 94(4): e01819-19.
4. Dickinson, P. J., et al. (2020). "Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis." Journal of Veterinary Internal Medicine, 34(4): 1587-1593.
5. Addie, D. D., et al. (2020). "Feline infectious peritonitis. ABCD guidelines on prevention and management." Journal of Feline Medicine and Surgery, 22(11): 1084-1097.
6. Gordon, C. J., et al. (2020). "Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency." Journal of Biological Chemistry, 295(20): 6785-6797.